LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Breath Ketone Analyzer Accurately Detects Ketosis in Type 1 Diabetes

By LabMedica International staff writers
Posted on 30 Sep 2021
Image: The Ketonix Breath Ketone Analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes (Photo courtesy of Ketonix)
Image: The Ketonix Breath Ketone Analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes (Photo courtesy of Ketonix)
The presence of high levels of ketones in the bloodstream is a common complication of diabetes, which if left untreated can lead to ketoacidosis. Ketones build up when there is insufficient insulin to help fuel the body’s cells.

High levels of ketones are more common in people with type 1 diabetes (T1D) or people with advanced type 2 diabetes. The most accurate way of testing for ketones is to use a blood glucose meter which can test for ketones as well as blood glucose levels. Urine can be tested for ketone levels; however, the testing of urine means that the level is representative of the ketone levels up to a few hours ago.

Medical Scientists at the University of Colorado (Aurora, CO, USA) assessed the accuracy of a breath ketone analyzer to detect ketosis in adults and children with type 1 diabetes. They analyzed data from adults and children aged 6 years or older that had type 1 diabetes for at least a year. Participants were given a breath ketone analyzer (Ketonix, Varberg, Sweden) and a blood ketone meter (Precision Xtra, Abbott Diabetes Care, Alameda, CA, USA) to measure ketones for 90 days. For 90 days, participants were asked to check ketones at least once daily, if their blood glucose was more than 300 mg/dL, or if they were having diabetic ketoacidosis symptoms. Measurements taken in the morning were considered fasting measurements, whereas all others were considered non-fasting.

The investigators reported that a total of 500 measurements from 19 adults and children with type 1 diabetes were analyzed. There was a significant association between the breath ketone analyzer and blood ketone meter results in non-fasting adults, but not in children. In adults, a cut-off of 3.9 PPM on the breath ketone analyzer maximized the Youden Index with an AUC of 0.73. This cut-off for the breath ketone analyzer had 94.7% sensitivity and 54.2% specificity to detect ketosis (≥0.6 mmol/L in blood ketone meter).

Halis Kaan Akturk, MD, an Endocrinologist and senior author of the study, said, “We found that morning fasting results in adults can be falsely higher in some individuals. We also included some adults with type 1 diabetes using SGLT2 inhibitors that already have higher ketone levels at baseline. A breath ketone analyzer can be a good screening tool in patients that are at high risk for ketosis.”

The authors concluded that the breath ketone analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes. The study was published on August 27, 2021 in the Journal of Diabetes and its Complications.

Related Links:
University of Colorado
Ketonix
Abbott Diabetes Care


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more